Development and characterization of an anti-rituximab monoclonal antibody panel
During the development of monoclonal antibodies (mAbs) and other therapeutic proteins, immunogenicity, in particular the induction of anti-drug antibodies (ADAs), is an important concern, and thus immunogenicity assessment is a requirement for their approval. Establishment of appropriate methods for...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | anglès |
| Publicat: |
2018
|
| Accés en línia: | https://doi.org/10.1080/19420862.2018.1424610 https://www.tandfonline.com/doi/pdf/10.1080/19420862.2018.1424610?needAccess=true |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|